Matt Dellatorre

Stock Analyst at Goldman Sachs

(2.63)

# 3,059

Out of 5,182 analysts

5

Total ratings

100%

Success rate

33.28%

Average return

Main Sectors:

Top Industries:

Drug Manufacturers - Specialty & Generic

Stocks Rated by Matt Dellatorre

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	TEVA Teva Pharmaceutical Industries	Maintains: Buy	$36 → $45	$35.35	+27.30%	4	Feb 9, 2026
	VTRS Viatris	Initiates: Neutral	$10	$15.20	-34.21%	1	Jun 6, 2025

Teva Pharmaceutical Industries

Feb 9, 2026

Maintains: Buy

Price Target: $36 → $45

Current: $35.35

Upside: +27.30%

Viatris

Jun 6, 2025

Initiates: Neutral

Price Target: $10

Current: $15.20

Upside: -34.21%